Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · IEX Real-Time Price · USD
36.92
+0.60 (1.65%)
At close: May 24, 2024, 4:00 PM
36.17
-0.75 (-2.03%)
After-hours: May 24, 2024, 7:30 PM EDT

Celldex Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for CLDX stock have an average target of 66, with a low estimate of 27 and a high estimate of 90. The average target predicts an increase of 78.76% from the current stock price of 36.92.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $27 $66 $80 $90
Change -26.87% +78.76% +116.68% +143.77%

Analyst Ratings

The average analyst rating for CLDX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Dec '23Jan '24Feb '24Mar '24Apr '24May '24
Strong Buy 112222
Buy 222222
Hold 111111
Sell 000000
Strong Sell 000000
Total 445555

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$80
Strong Buy Reiterates $80 +116.68% May 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$80
Strong Buy Reiterates $80 +116.68% May 7, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$80
Strong Buy Reiterates $80 +116.68% Apr 17, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$67
Buy Reiterates $67 +81.47% Mar 22, 2024
Guggenheim
Guggenheim
Strong Buy
Maintains
$72$90
Strong Buy Maintains $72$90 +143.77% Feb 27, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
2.77M
from 6.88M
Decreased by -59.70%
Revenue Next Year
2.83M
from 2.77M
Increased by 2.05%
EPS This Year
-2.36
from -2.92
EPS Next Year
-3.01
from -2.36
Year 2019202020212022202320242025202620272028
Revenue
3.57M7.42M4.65M2.36M6.88M2.77M2.83M2.30M60.87M414.30M
Revenue Growth
-62.54%107.61%-37.30%-49.32%192.02%-59.70%2.05%-18.93%2,552.46%580.59%
EPS
-3.51-2.02-1.64-2.40-2.92-2.36-3.01-3.69-3.660.30
EPS Growth
----------
No. Analysts -----109844
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 5.5M 5.7M 5.3M 125.0M 764.2M
Avg 2.8M 2.8M 2.3M 60.9M 414.3M
Low n/a n/a n/a n/a 157.0M

Revenue Growth

Revenue Growth 20242025202620272028
High
-20.7%
104.4%
85.4%
5,344.4%
1,155.4%
Avg
-59.7%
2.1%
-18.9%
2,552.5%
580.6%
Low - - - -
157.9%

EPS Forecast

EPS 20242025202620272028
High -1.99 -2.80 -2.80 -3.71 2.36
Avg -2.36 -3.01 -3.69 -3.66 0.30
Low -2.60 -3.36 -4.48 -3.57 -1.64

EPS Growth

EPS Growth 20242025202620272028
High - - - - -
Avg - - - - -
Low - - - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.